Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

JAK2 Haplotype SNP Analysis in Essential Thrombocythemia: Clinical and JAK2 V617F Allele Burden Correlates in 226 Patients.

Animesh D. Pardanani, MBBS, PhD, Terra Lasho, Christy Finke, BS, Kebede Hussein, MD, Michelle Elliott, MB, BCh, Ayalew Tefferi, MD

Blood (2009) 114 (22): 2893.

https://doi.org/10.1182/blood.V114.22.2893.2893

Published: 2009

Journal Articles

A JAK2 Germline Genetic Variation Is Associated with Shortened Survival in Primary Myelofibrosis: Clinical and JAK2V617F Allele Burden Correlates of rs12343867 SNP Genotype in 132 Cases.

Ayalew Tefferi, MD, Terra Lasho, Christy Finke, BS, Kebede Hussein, MD, Michelle Elliott, MB, BCh, Animesh D. Pardanani, MBBS, PhD

Blood (2009) 114 (22): 2895.

https://doi.org/10.1182/blood.V114.22.2895.2895

Published: 2009

Journal Articles

IPSS-Independent Cytogenetic Risk Categorization in Primary Myelofibrosis.

Kebede Hussein, MD, Animesh D. Pardanani, MBBS, PhD, Daniel van Dyke, Curtis A. Hanson, MD, Ayalew Tefferi, MD

Blood (2009) 114 (22): 2909.

https://doi.org/10.1182/blood.V114.22.2909.2909

Published: 2009

Journal Articles

Phase 1/2 Dose Finding Study of Pomalidomide in Myelofibrosis.

Ruben A. Mesa, MD, Animesh D. Pardanani, MBBS, PhD, Kebede Hussein, MD, Wenting Wu, PhD, Susan Schwager, Mark R. Litzow, MD, William J Hogan, MD, Ayalew Tefferi, MD

Blood (2009) 114 (22): 2911.

https://doi.org/10.1182/blood.V114.22.2911.2911

Published: 2009

Journal Articles

Weight Loss, Splenomegaly, and Hypocholesterolemia in Myeloproliferative Neoplasms: Patterns and Relevance from the Pre JAK2 Inhibitor Era.

Ruben A. Mesa, MD, Susan Schwager, Jocelin Huang, MD, Animesh D. Pardanani, MBBS, PhD, Kebede Hussein, MD, John Camoriano, MD, Ayalew Tefferi, MD

Blood (2009) 114 (22): 3918.

https://doi.org/10.1182/blood.V114.22.3918.3918

Published: 2009

Journal Articles

Transfusion Need at Diagnosis or Its Development During the First Year of Diagnosis in Primary Myelofibrosis: Effect On Survival and Correlation with JAK2 and TET2 Mutational Status.

Ayalew Tefferi, MD, Sergio Siragusa, MD, Rakhee Vaidya, Susan Schwager, Kebede Hussein, MD, Curtis A. Hanson, MD, Animesh D. Pardanani, MBBS, PhD, Francisco Cervantes, Francesco Passamonti

Blood (2009) 114 (22): 1909.

https://doi.org/10.1182/blood.V114.22.1909.1909

Published: 2009

Journal Articles

Assessment and Monitoring of Constitutional Symptoms in Patients with Myelofibrosis: A Proposed New Instrument the Myelofibrosis Symptom Assessment Form (MFSAF).

Ruben A. Mesa, MD, FACP, Susan Schwager, Deepti Radia, MD, Andrea Cheville, MD, Kebede Hussein, MD, Joyce Niblack, JD, Animesh D. Pardanani, MBBS, PhD, David P. Steensma, MD, FACP, Mark R. Litzow, MD, Candido E. Rivera, MD, John Camoriano, MD, Srdan Verstovsek, Jeffrey Sloan, PhD, Claire Harrison, MD, Ayalew Tefferi, MD

Blood (2008) 112 (11): 1754.

https://doi.org/10.1182/blood.V112.11.1754.1754

Published: 2008

Journal Articles

Red Blood Cell Transfusion Requirement at Diagnosis Adversely Affects Both Overall and Leukemia-Free Survival in Primary Myelofibrosis - Increased Serum Ferritin or Total Transfusion Burden Does Not

Ayalew Tefferi, MD, Ruben A. Mesa, MD, FACP, Jocelin Huang, MD, Animesh D. Pardanani, MBBS, PhD, Kebede Hussein, MD, Susan Schwager, Curtis A. Hanson, David P. Steensma, MD, FACP

Blood (2008) 112 (11): 5232.

https://doi.org/10.1182/blood.V112.11.5232.5232

Published: 2008

Journal Articles

Dynamics, and Prognostic Impact, of Weight Loss in Primary Myelofibrosis

Ruben A. Mesa, MD, FACP, Susan Schwager, Jocelin Huang, MD, Kebede Hussein, MD, Animesh D. Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2008) 112 (11): 5224.

https://doi.org/10.1182/blood.V112.11.5224.5224

Published: 2008

Journal Articles

Peripheral Blood Cytogenetic Studies in Hematological Neoplasms: Predictors of Obtaining Metaphases for Analysis.

Kebede Hussein, MD, Rhett P. Ketterling, MD, Gordon W. Dewald, PhD, Rachael L. Hulshizer, Daniel G. Kuffel, Anne E. Wiktor, Daniel L. Van Dyke, PhD, Ayalew Tefferi, MD

Blood (2007) 110 (11): 3504.

https://doi.org/10.1182/blood.V110.11.3504.3504

Published: 2007

Journal Articles

JAK2V617F Mutation Screening as Part of the Hypercoagulable Workup in the Absence of Splanchnic Vein Thrombosis: Assessment of Value in a Series of 664 Consecutive Patients.

Animesh Pardanani, MBBS, PhD, Terra L. Lasho, MT, Kebede Hussein, MD, Susan Schwager, Christy Finke, Rajiv K. Pruthi, MBBS, Ayalew Tefferi, MD

Blood (2007) 110 (11): 3191.

https://doi.org/10.1182/blood.V110.11.3191.3191

Published: 2007

Journal Articles

Hypocholesterolemia Is Independently Associated with Decreased Survival in Patients with Primary Myelofibrosis: An Analysis of Lipid Profiles in 558 Myeloproliferative Patients.

Ruben A. Mesa, MD, Jocelin Huang, MD, Susan Schwager, Animesh Pardanani, MD, Kebede Hussein, MD, David Dingli, MD, Michael Jensen, MD, Elizabeth Haglind, MD, Ayalew Tefferi, MD

Blood (2007) 110 (11): 2548.

https://doi.org/10.1182/blood.V110.11.2548.2548

Published: 2007

Journal Articles

Peripheral Blood Cytogenetic Studies in Myelofibrosis: Overall Yield and Comparison with Bone Marrow Cytogenetic Studies

Kebede Hussein, MD, Rhett P. Ketterling, MD, Gordon W. Dewald, PhD, Daniel L. Van Dyke, PhD, Ruben Mesa, MD, Ayalew Tefferi, MD

Blood (2007) 110 (11): 1547.

https://doi.org/10.1182/blood.V110.11.1547.1547

Published: 2007

Journal Articles

Predictive Value of the Pre-Operative CT Scan for Splenectomy in Patients with Primary, and Post Essential Thrombocythemia/Post Polycythemia Vera Myelofibrosis.

Ruben A. Mesa, MD, Brian Bartholmai, MD, Chin Y. Li, MD, Susan Schwager, Animesh Pardanani, MD, PHD, Kebede Hussein, MD, Ayalew Tefferi, MD

Blood (2007) 110 (11): 4632.

https://doi.org/10.1182/blood.V110.11.4632.4632

Published: 2007

NARROW

JAK2 Haplotype SNP Analysis in Essential Thrombocythemia: Clinical and JAK2 V617F Allele Burden Correlates in 226 Patients.

A JAK2 Germline Genetic Variation Is Associated with Shortened Survival in Primary Myelofibrosis: Clinical and JAK2V617F Allele Burden Correlates of rs12343867 SNP Genotype in 132 Cases.

IPSS-Independent Cytogenetic Risk Categorization in Primary Myelofibrosis.

Phase 1/2 Dose Finding Study of Pomalidomide in Myelofibrosis.

Weight Loss, Splenomegaly, and Hypocholesterolemia in Myeloproliferative Neoplasms: Patterns and Relevance from the Pre JAK2 Inhibitor Era.

Transfusion Need at Diagnosis or Its Development During the First Year of Diagnosis in Primary Myelofibrosis: Effect On Survival and Correlation with JAK2 and TET2 Mutational Status.

Assessment and Monitoring of Constitutional Symptoms in Patients with Myelofibrosis: A Proposed New Instrument the Myelofibrosis Symptom Assessment Form (MFSAF).

Red Blood Cell Transfusion Requirement at Diagnosis Adversely Affects Both Overall and Leukemia-Free Survival in Primary Myelofibrosis - Increased Serum Ferritin or Total Transfusion Burden Does Not

Dynamics, and Prognostic Impact, of Weight Loss in Primary Myelofibrosis

Peripheral Blood Cytogenetic Studies in Hematological Neoplasms: Predictors of Obtaining Metaphases for Analysis.

JAK2V617F Mutation Screening as Part of the Hypercoagulable Workup in the Absence of Splanchnic Vein Thrombosis: Assessment of Value in a Series of 664 Consecutive Patients.

Hypocholesterolemia Is Independently Associated with Decreased Survival in Patients with Primary Myelofibrosis: An Analysis of Lipid Profiles in 558 Myeloproliferative Patients.

Peripheral Blood Cytogenetic Studies in Myelofibrosis: Overall Yield and Comparison with Bone Marrow Cytogenetic Studies

Predictive Value of the Pre-Operative CT Scan for Splenectomy in Patients with Primary, and Post Essential Thrombocythemia/Post Polycythemia Vera Myelofibrosis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only